Robert L Van Nostrand insider trades
Open-market stock purchases and sales by Robert L Van Nostrand, Director at SELLAS Life Sciences Group, Inc, from SEC Form 4 filings since Jun 4, 2010.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jan 7, 2026 | SLS SELLAS Life Sciences Group, Inc | Bought (not open market) | — |
Companies traded
- SLS SELLAS Life Sciences Group, Inc: 1 buy, last Jan 7, 2026
- ITCI Intra-Cellular Therapies, Inc: 1 buy, 7 sales, last Apr 2, 2025
- YTEN Yield10 Bioscience, Inc: other filings, last Mar 28, 2024
- ACHN Achillion Pharmaceuticals Inc: other filings, last Jan 28, 2020
- ENUM Enumeral Biomedical Holdings, Inc: 1 buy, last Jan 3, 2017
- MBLX Metabolix, Inc: 1 buy, last Sep 10, 2015
Get free alerts when Robert L Van Nostrand files a new trade →